The clinical value of Circulating Tumor Cells (CTC) in patients undergoing pulmonary metastasectomy for metastatic colorectal cancer
| Project/Area Number |
22791326
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Thoracic surgery
|
|---|
| Research Institution | Hyogo Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Keywords | 循環血液中腫瘍細胞(CTC) / 結腸直腸癌肺転移 / 循環血液中腫瘍細胞(CTC / 循環腫瘍細胞 / 循環内皮細胞 / 肺転移 / 手術 |
|---|
| Research Abstract |
In this context, we conducted a prospective study to evaluate whether preoperative Circulating tumor cells (CTC)-count predicts survival after pulmonary metastasectomy in patients with metastatic colorectal cancer. Preoperative CTC-count was quantitatively evaluated with a 7.5-mL of peripheral blood sample using CellSearchTM system. Based on previously published criteria, patients were divided into favorable group and unfavorable group according to preoperative CTC-count of < 3 or ≧ 3 /7.5mL, respectively. The estimated 5-year survival rates were 80.4% in favorable group (n=50) and 0% in unfavorable group (n=2). There was a significant difference in postoperative survival between favorable and unfavorable groups (p<0.001). An elevated preoperative CTC-count (CTC≧3 /7.5mL) is an independent poor prognostic factor in patients with metastatic colorectal cancer. Pulmonary metastasectomy in such cases should be reconsidered even when they meet conventional surgical criteria.
|
Report
(4 results)
Research Products
(9 results)
